Danish Dementia Research Centre (DDRC), Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen Ø, Denmark.
Department of Affective Disorders, Aarhus University Hospital, Psychiatry, Aarhus N, Denmark.
J Alzheimers Dis. 2021;79(4):1459-1470. doi: 10.3233/JAD-200627.
Studies have shown declining use of potentially inappropriate medication (PIM), medication where risks associated with use outweigh potential benefits in older people. However, the trend in people with dementia remains unknown.
To test the hypothesis that the use of PIM has decreased in people with dementia in line with the declining use in the general older population.
Repeated cross-sectional register-based study of the entire Danish population aged ≥65 years (2000: N = 802,106; 2015: N = 1,056,476). PIM was identified using the Danish "Red-yellow-green list". Changes in the use of PIM were examined by calculating the annual prevalence of filling prescriptions for at least one PIM in older people with and without dementia. Characteristics of the study population were examined annually including comorbidity.
From 2000 to 2015, the prevalence of PIM use decreased from 54.7%to 43.5%in people with dementia and from 39.5%to 28.8%in people without dementia; the decrease was significant across all age groups and remained so in a sensitivity analysis where antipsychotics were removed. During the same period, comorbidity scores increased in people with and without dementia.
The declining use of PIM in people with dementia from 2000 to 2015 parallels the trend in the general older population. The use of PIM decreased despite increasing levels of comorbidity and was not solely attributable to the decreasing use of antipsychotics in people with dementia. However, PIM use remained more widespread in people with dementia who may be more vulnerable to the risks associated with PIM.
研究表明,在老年人中,与使用相关的风险超过潜在益处的潜在不适当药物(PIM)的使用正在减少。然而,痴呆症患者的趋势尚不清楚。
检验以下假设,即随着一般老年人群中 PIM 使用的减少,痴呆症患者中 PIM 的使用也会减少。
这是一项基于登记的丹麦≥65 岁人群(2000 年:N=802106;2015 年:N=1056476)的重复横断面研究。使用丹麦的“红-黄-绿清单”来识别 PIM。通过计算痴呆症患者和无痴呆症患者每年至少开具一份 PIM 处方的流行率,来检查 PIM 使用的变化。每年检查研究人群的特征,包括合并症。
从 2000 年到 2015 年,痴呆症患者中 PIM 使用的流行率从 54.7%下降到 43.5%,无痴呆症患者中 PIM 使用的流行率从 39.5%下降到 28.8%;在所有年龄组中均呈下降趋势,在去除抗精神病药物的敏感性分析中仍然如此。在此期间,痴呆症患者和无痴呆症患者的合并症评分均增加。
2000 年至 2015 年,痴呆症患者中 PIM 使用的下降与一般老年人群的趋势一致。尽管合并症水平增加,但 PIM 的使用仍在减少,这不仅仅归因于痴呆症患者中抗精神病药物使用的减少。然而,痴呆症患者中 PIM 的使用仍然更为普遍,他们可能更容易受到 PIM 相关风险的影响。